Acadia Pharmaceuticals (ACAD) Shares Issued (2016 - 2025)
Historic Shares Issued for Acadia Pharmaceuticals (ACAD) over the last 17 years, with Q3 2025 value amounting to $9.4 million.
- Acadia Pharmaceuticals' Shares Issued rose 341604.48% to $9.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $29.2 million, marking a year-over-year increase of 18308.44%. This contributed to the annual value of $6.8 million for FY2024, which is 7276.06% down from last year.
- According to the latest figures from Q3 2025, Acadia Pharmaceuticals' Shares Issued is $9.4 million, which was up 341604.48% from $16.0 million recorded in Q2 2025.
- Acadia Pharmaceuticals' 5-year Shares Issued high stood at $16.0 million for Q2 2025, and its period low was $268000.0 during Q3 2024.
- In the last 5 years, Acadia Pharmaceuticals' Shares Issued had a median value of $3.6 million in 2024 and averaged $4.5 million.
- Its Shares Issued has fluctuated over the past 5 years, first soared by 434285.71% in 2023, then plummeted by 9789.82% in 2024.
- Acadia Pharmaceuticals' Shares Issued (Quarter) stood at $4.4 million in 2021, then plummeted by 63.02% to $1.6 million in 2022, then surged by 236.68% to $5.4 million in 2023, then plummeted by 63.77% to $2.0 million in 2024, then skyrocketed by 378.57% to $9.4 million in 2025.
- Its Shares Issued was $9.4 million in Q3 2025, compared to $16.0 million in Q2 2025 and $1.8 million in Q1 2025.